<https://rdf.molmedb.upol.cz/reference/ref1243> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17291>;
	<http://purl.org/dc/terms/bibliographicCitation> "Washburn WN.: Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2. J Med Chem, Volume 52 (7), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm8013019"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17026>,
		<https://identifiers.org/molmedb/MM17193>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target73>;
	<http://purl.org/ontology/bibo/pmid> "19243175"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra55904> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1243> .
<https://rdf.molmedb.upol.cz/transporter/tra31643> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1243> .
<https://rdf.molmedb.upol.cz/transporter/tra55932> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1243> .